These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6114739)

  • 1. Adrenergic hypersensitivity after beta-blocker withdrawal.
    Ross PJ; Lewis MJ; Sheridan DJ; Henderson AH
    Br Heart J; 1981 Jun; 45(6):637-42. PubMed ID: 6114739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors relating to the beta blocker withdrawal syndrome.
    Henderson A; Sheridan D; Ross J; Lewis M
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):25-8. PubMed ID: 6124208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 4. Rebound effect after stopping beta-blockers.
    Lewis MJ; Ross PJ; Henderson AH
    Br Med J; 1979 Sep; 2(6190):606. PubMed ID: 40664
    [No Abstract]   [Full Text] [Related]  

  • 5. beta-Adrenoceptor hypersensitivity after stopping oxprenolol: discrepant findings not attributable to methodology.
    Singh H; Rimmer A; Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1983 Dec; 16(6):722-4. PubMed ID: 6318786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
    Rangno RE; Langlois S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):345S-351S. PubMed ID: 6125187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blocker withdrawal.
    Frishman WH
    Am J Cardiol; 1987 May; 59(13):26F-32F. PubMed ID: 2883874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
    de Mey D
    Acta Cardiol; 1972; ():Suppl 15:255-6. PubMed ID: 4147609
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the sympathetic nervous system in the pathogenesis of chronic stable angina. Implications for the mechanism of action of beta-blockers.
    Chierchia S; Muiesan L; Davies A; Balasubramian V; Gerosa S; Raftery EB
    Circulation; 1990 Sep; 82(3 Suppl):II71-81. PubMed ID: 1975525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-adrenergic blockade withdrawal phenomenon.
    Prichard BN; Tomlinson B; Walden RJ; Bhattacharjee P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S56-62. PubMed ID: 6188921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic actions of nitrite-beta-adrenergic blocking agents in the therapy of angina pectoris. Pharmacologic and therapeutic rationale.
    Klein HO; Berger HJ
    Cardiology; 1973; 58(6):313-25. PubMed ID: 4153989
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of action of beta blockers in angina pectoris.
    Ablad B; Carlsson E; Ek L; Johnsson G
    Scott Med J; 1977 Jan; 22(1):52-63. PubMed ID: 13495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular responses in hyperthyroidism before and during beta-adrenoceptor blockade: evidence against adrenergic hypersensitivity.
    Forfar JC; Stewart J; Sawers A; Toft AD
    Clin Endocrinol (Oxf); 1982 May; 16(5):441-52. PubMed ID: 7083598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 18. Abrupt withdrawal of atenolol in patients with severe angina. Comparison with the effects of treatment.
    Walker PR; Marshall AJ; Farr S; Bauminger B; Walters G; Barritt DW
    Br Heart J; 1985 Mar; 53(3):276-82. PubMed ID: 3970785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.